| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $85.3M | -51.1% |
| Cost of Revenue | $42.8M | -52.5% |
| Gross Profit | $42.5M | -49.5% |
| R&D Expense | $26.0M | -58.4% |
| SG&A Expense | $109.9M | -29.8% |
| Operating Income | -$110.2M | +37.1% |
| Pre-tax Income | -$96.7M | +30.1% |
| Income Tax | -$37.9M | -6710.1% |
| Net Income | -$74.9M | +46.1% |
| EPS (Basic) | -$0.20 | +61.5% |
| EPS (Diluted) | -$0.20 | +61.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.9M | -27.5% |
| Accounts Receivable | $13.4M | -60.0% |
| Inventory | $20.0M | -51.0% |
| Current Assets | $454.3M | +20.9% |
| Total Assets | $567.8M | -7.3% |
| Current Liabilities | $108.3M | +64.4% |
| Total Liabilities | $143.5M | +2.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.3M | +48.2% |
| Capital Expenditures | $8.3M | -0.6% |
| Investing Cash Flow | $27.4M | -92.5% |
| Financing Cash Flow | $570K | +100.6% |
| Free Cash Flow | -$82.6M | +45.6% |
| $424.3M |
| -10.1% |